Skip to content
Recall Observatory FDA recall evidence

Drug product

PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-710-21

D-0538-2025

April 21, 2025

Class II

Product summary

Firm
Mckesson Medical-Surgical Inc. Corporate Office
Event
Event 97110
Status
Ongoing
Classification
Class II
Quantity
6 Pre-filled syringes
Official record key
drug-enforcement:D-0538-2025

Official wording

Reason: CGMP Deviations; potential temperature excursions due to transit delays

Code information: Lot: 1180924, Expiration date: 6/30/2027.

Distribution pattern: Within the U.S - OH, VA, FL.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations